CLARA M. AMBRUS, M.D., Ph.D.; SIDNEY ANTHONE, M.D.; CSABA HORVATH, Ph.D.; KRISHNA KALGHATGI, Ph.D.; AMOL S. LELE, M.D.; GIORGINA EAPEN, M.D.; JULIAN L. AMBRUS, M.D., Ph.D.; A. JOHN RYAN, M.D.; PHILIP LI, Ph.D.
Multitubular enzyme reactors with immobilized enzymes were developed to achieve depletion of circulating substrate by extracorporeal means. To act as prototypes, reactors were prepared with immobilized L-phenylalanine ammonia-lyase, an enzyme that metabolizes phenylalanine to trans-cinnamic acid and ammonia without the need for a coenzyme. We report the first application of phenylalanine ammonia-lyase reactors in an extracorporeal circulation system in a patient with phenylketonuria. A phenylalanine level of 1.82 mmol/L (for the last 6 years) decreased to 1.24 mmol/L after 5.5. hours of treatment, without the enzyme entering the circulation. Total phenylalanine depletion from blood and tissue stores was estimated at 1800 mg. The hemodialysis-like procedure proved to be without side effects, specific for phenylalanine, and suitable in the management of pregnant women with phenylketonuria and late-onset hyperphenylalaninemia. The extracorporeal use of enzyme reactors for temporary enzyme replacement represents a new, safe, and effective therapeutic modality.
AMBRUS CM, ANTHONE S, HORVATH C, KALGHATGI K, LELE AS, EAPEN G, et al. Extracorporeal Enzyme Reactors for Depletion of Phenylalanine in Phenylketonuria. Ann Intern Med. 1987;106:531–537. doi: 10.7326/0003-4819-106-4-531
Download citation file:
Published: Ann Intern Med. 1987;106(4):531-537.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use